XelyoMax is at the forefront of the new generation of cell therapy; it is safe, standardized in the right concentration which triggers the most optimal effect when introduced.
Studies are showing incredible results in the domain of Wound Healing, Orthopedics and Cosmetic treatments because of this.
More specifically, XelyoMax has proven to be extremely efficient in the management of degenerative changes of the musculoskeletal system including bone, joints, muscles and ligaments.
A recent study published in Annals of Rheumatic Diseases has concluded that allogeneic L-GF(now used in the proprietary XelyoMax process) were well-tolerated and showed encouraging results in patients with symptomatic knee osteoarthritis in terms of improved pain, stiffness and function in addition to decreased knee effusion.
EVALUATING THE EFFECTIVENESS OF INTRA-ARTICULAR KNEE INJECTION USING ALLOGENIC PLATELET DERIVED LYOPHILIZED GROWTH FACTORS IN EGYPTIAN PATIENTS WITH SYMPTOMATIC PRIMARY KNEE OSTEOARTHRITIS
Rasmia Elgohary,Amany Diab,Hala Elgndy,Hossam Fahmy,Kamel Gado
Annals of Rheumatic diseases. BMJ journals. Volume 78, Issue Suppl 2
XelyoMax is an innovative clinical product that is used to improve cell rejuvenation, wound healing and orthopaedic conditions. Studies and treatment indicate very promising results. XelyoMax can be used in clinical and non-clinical areas. Important clinical studies are being conducted and results are expected soon.
For veterinary solutions, visit (www.XelyoVet.com)